Phosphorus metabolite changes in temporal lobes of subjects with schizotypal personality disorder

Schizophrenia Research

Volumn 58, Issue 2-3, 2002, Pages 201-203

  Fukuzako, Hiroshi ^a   Kodama, Satoshi ^a   Fukuzako, Tsuyoshi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Magnetic resonance spectroscopy; Phosphorus metabolites; Schizotypal personality disorder; Temporal lobe

Indexed keywords

ESTER DERIVATIVE; MEMBRANE PHOSPHOLIPID; PHOSPHORUS; PHOSPHORUS 31;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IN VIVO STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PHOSPHATE METABOLISM; PRIORITY JOURNAL; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; TEMPORAL LOBE;

ADULT; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHOSPHORUS; SCHIZOTYPAL PERSONALITY DISORDER; TEMPORAL LOBE;

EID: 0036888525     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(02)00157-3     Document Type: Article

References (12)

1. 31P MRS of the schizophrenic brain in vivo. J. Comput. Assisted Tomogr. 23:1999;272-275.
2. Buchsbaum M.S., Trestman R.L., Hazlett E., Siegel B.V. Jr., Germans M., Haznedar M., O'Flaithbheartaigh S., Wei T., Silverman J., Siever L.J. Ventricular volume and asymmetry in schizotypal personality disorder and schizophrenia assessed with magnetic resonance imaging. Schizophr. Res. 27:1997;21-28.
3. Buchsbaum M.S., Yang S., Hazlett E., Siegel B.V. Jr., Schaefer C.H., Luu-Hsia C., Tang C., Herrera S., Solimando A.C., Losonczy M., Silverman J., Siever L.J. Ventricular volume and asymmetry in schizotypal personality disorder and schizophrenia assessed with magnetic resonance imaging. Schizophr. Res. 27:1997;45-53.
4. Dickey C.C., Shenton M.E., Hirayasu Y., Fischer I., Voglmaier M.M., Niznikiewicz M.A., Seidman L.J., Faraone S., McCarley R.W. Large CSF volume not attributable to ventricular volume in schizotypal personality disorder. Am. J. Psychiatry. 157:2000;48-54.
5. Fukuzako H. Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy. World J. Biol. Psychiatry. 2:2001;70-82.
6. Fukuzako H., Fukuzako T., Kodama S., Hashiguchi T., Takigawa M., Fujimoto T. Haloperidol improves membrane phospholipid abnormalities in temporal lobes of schizophrenic patients. Neuropsychopharmacology. 21:1999;542-549.
7. Horrobin D.F. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr. Res. 30:1998;193-208.
8. Keshavan M.S., Stanley J.A., Pettegrew J.W. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings - Part II. Biol. Psychiatry. 48:2000;369-380.
9. Klemm S., Rzanny R., Riehemann S., Volz H.P., Schmidt B., Gerhard U.J., Filz C., Schönberg A., Mentzel H.J., Kaiser W.A., Blanz B. Cerebral phosphorus metabolism in first-degree relatives of patients with schizophrenia. Am. J. Psychiatry. 158:2001;958-960.
10. 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls. Biol. Psychiatry. 45:1999;687-693.
11. 31P MRS study. Biol. Psychiatry. 45:1999;57S.
12. Stanley J.A., Pettegrew J.W., Keshavan M.S. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings - Part I. Biol. Psychiatry. 48:2000;357-368.